Chemours Stock Price, News & Analysis (NYSE:CC)

$51.08 +0.94 (+1.87 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$51.08
Today's Range$50.41 - $51.59
52-Week Range$32.09 - $58.08
Volume1.66 million shs
Average Volume1.77 million shs
Market Capitalization$9.32 billion
P/E Ratio13.06
Dividend Yield1.33%
BetaN/A

About Chemours (NYSE:CC)

Chemours logoThe Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone+1-302-7731000

Debt

Debt-to-Equity Ratio4.74%
Current Ratio2.12%
Quick Ratio1.55%

Price-To-Earnings

Trailing P/E Ratio13.0639386189258
Forward P/E Ratio9.64
P/E Growth0.61

Sales & Book Value

Annual Sales$6.18 billion
Price / Sales1.51
Cash Flow$5.60 per share
Price / Cash9.12
Book Value$4.74 per share
Price / Book10.78

Profitability

Trailing EPS$3.91
Net Income$746 million
Net Margins12.06%
Return on Equity115.54%
Return on Assets10.83%

Miscellaneous

Employees7,000
Outstanding Shares182,520,000

Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Friday, December 1st. Stockholders of record on Thursday, February 15th will be given a dividend of $0.17 per share on Thursday, March 15th. This represents a $0.68 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Wednesday, February 14th. This is an increase from Chemours's previous quarterly dividend of $0.03. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours declared that its Board of Directors has authorized a stock repurchase program on Monday, December 4th 2017, which authorizes the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) announced its quarterly earnings data on Wednesday, February, 14th. The specialty chemicals company reported $1.19 EPS for the quarter, topping the Zacks' consensus estimate of $0.95 by $0.24. The specialty chemicals company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Chemours had a net margin of 12.06% and a return on equity of 115.54%. Chemours's revenue for the quarter was up 19.1% compared to the same quarter last year. During the same period last year, the company earned $0.08 earnings per share. View Chemours' Earnings History.

When will Chemours make its next earnings announcement?

Chemours is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Chemours.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY18 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of $4.95-5.60 for the period, compared to the Thomson Reuters consensus estimate of $5.09.

Where is Chemours' stock going? Where will Chemours' stock price be in 2018?

8 Wall Street analysts have issued 12-month price objectives for Chemours' stock. Their forecasts range from $55.00 to $66.00. On average, they expect Chemours' share price to reach $57.81 in the next twelve months. View Analyst Ratings for Chemours.

Who are some of Chemours' key competitors?

Who are Chemours' key executives?

Chemours' management team includes the folowing people:

  • Richard H. Brown, Independent Chairman of the Board (Age 69)
  • Mark P. Vergnano, President, Chief Executive Officer, Director (Age 59)
  • Mark E. Newman, Chief Financial Officer, Senior Vice President (Age 54)
  • Paul Kirsch, President - Fluoroproducts (Age 53)
  • Christian W. Siemer, President - Chemical Solutions (Age 58)
  • Eugene Bryan Snell, President - Titanium Technologies (Age 60)
  • Elizabeth Albright, Senior Vice President - Human Resources (Age 50)
  • Erich Parker, Vice President of Corporate Communications, Chief Brand Officer (Age 65)
  • David Charles Shelton, Corporate Secretary and General Counsel (Age 53)
  • Curtis V. Anastasio, Independent Director (Age 60)

Who owns Chemours stock?

Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.52%), TIAA CREF Investment Management LLC (1.80%), Renaissance Technologies LLC (1.64%), Bank of New York Mellon Corp (1.39%), Allianz Asset Management GmbH (1.21%) and Two Sigma Advisers LP (0.90%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Paul Kirsch, Richard H Brown and Stephen D Newlin. View Institutional Ownership Trends for Chemours.

Who sold Chemours stock? Who is selling Chemours stock?

Chemours' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Two Sigma Investments LP, Renaissance Technologies LLC, Two Sigma Advisers LP, Deutsche Bank AG, Cornerstone Capital Management Holdings LLC., Allianz Asset Management GmbH and Jennison Associates LLC. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

Who bought Chemours stock? Who is buying Chemours stock?

Chemours' stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., TIAA CREF Investment Management LLC, AXA, Swiss National Bank, Gotham Asset Management LLC, UBS Asset Management Americas Inc., Victory Capital Management Inc. and First Trust Advisors LP. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, Mark Newman, Richard H Brown and Stephen D Newlin. View Insider Buying and Selling for Chemours.

How do I buy Chemours stock?

Shares of Chemours can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of Chemours stock can currently be purchased for approximately $51.08.

How big of a company is Chemours?

Chemours has a market capitalization of $9.32 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.91 on an earnings per share basis. Chemours employs 7,000 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 Market St, WILMINGTON, DE 19898-1100, United States. The specialty chemicals company can be reached via phone at +1-302-7731000 or via email at [email protected]


MarketBeat Community Rating for Chemours (CC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  375
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chemours (NYSE:CC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.863.003.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $57.81$57.86$52.71$51.83
Price Target Upside: 7.88% upside25.06% upside1.67% upside16.72% upside

Chemours (NYSE:CC) Consensus Price Target History

Price Target History for Chemours (NYSE:CC)

Chemours (NYSE:CC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/30/2018Morgan StanleyInitiated CoverageEqual -> Equal Weight$57.50MediumView Rating Details
12/6/2017BarclaysReiterated RatingBuy$60.00LowView Rating Details
12/6/2017Goldman Sachs GroupDowngradeBuy -> Neutral$55.00MediumView Rating Details
12/4/2017Jefferies GroupBoost Price TargetBuy$66.00HighView Rating Details
8/10/2017ArgusReiterated RatingBuy$50.00 -> $55.00HighView Rating Details
8/4/2017JPMorgan Chase & Co.Boost Price TargetOverweight$55.00LowView Rating Details
8/4/2017CitigroupBoost Price TargetBuy$45.00 -> $59.00HighView Rating Details
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 -> $55.00LowView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Chemours (NYSE:CC) Earnings History and Estimates Chart

Earnings by Quarter for Chemours (NYSE:CC)

Chemours (NYSE CC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$1.12N/AView Earnings Details
2/14/2018Q4 2017$0.95$1.19$1.55 billion$1.58 billionViewListenView Earnings Details
11/2/2017Q3 2017$1.01$1.12$1.59 billion$1.58 billionViewN/AView Earnings Details
8/2/2017Q2 2017$0.85$0.87$1.49 billion$1.59 billionViewListenView Earnings Details
5/1/2017Q1 2017$0.50$0.75$1.32 billion$1.44 billionViewListenView Earnings Details
2/15/2017Q416$0.29$0.08$1.24 billion$1.30 billionViewN/AView Earnings Details
11/6/2016Q3 2016$0.25$0.61$1.29 billion$1.40 billionViewN/AView Earnings Details
8/8/2016Q216$0.17$0.27$1.42 billion$1.38 billionViewN/AView Earnings Details
5/2/2016Q116$0.02$0.06$1.27 billion$1.30 billionViewN/AView Earnings Details
2/23/2016Q415$0.09$0.03$1.36 billion$1.40 billionViewListenView Earnings Details
11/5/2015Q315$0.26$0.40$1.52 billion$1.49 billionViewN/AView Earnings Details
8/6/2015Q215$0.33$0.24$1.53 billion$1.50 billionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Chemours (NYSE:CC) Earnings Estimates

Current Year EPS Consensus Estimate: $5.3 EPS
Next Year EPS Consensus Estimate: $5.97 EPS

Dividends

Chemours (NYSE:CC) Dividend Information

Next Dividend:3/15/2018
Annual Dividend:$0.68
Dividend Yield:1.33%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:17.39% (Trailing 12 Months of Earnings)
12.83% (Based on This Year's Estimates)
11.39% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemours (NYSE:CC)

Chemours (NYSE:CC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/1/2017Quarterly$0.171.43%2/14/20182/15/20183/15/2018
11/7/2017quarterly$0.030.24%11/17/201711/20/201712/15/2017
8/2/2017quarterly$0.030.25%8/15/20178/17/20179/15/2017
4/27/2017quarterly$0.030.3%5/15/20175/17/20176/15/2017
2/14/2017quarterly$0.030.37%2/23/20172/27/20173/15/2017
11/2/2016quarterly$0.030.72%11/15/201611/17/201612/15/2016
8/3/2016quarterly$0.031.34%8/15/20168/17/20169/15/2016
4/27/2016quarterly$0.031.27%5/13/20165/17/20166/15/2016
2/23/2016quarterly$0.032.44%3/9/20163/11/20163/31/2016
9/1/2015quarterly$0.031.38%11/10/201511/13/201512/14/2015
7/24/2015special$0.557/30/20158/3/20159/11/2015
(Data available from 1/1/2013 forward)

Insider Trades

Chemours (NYSE CC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 77.01%
Insider Trades by Quarter for Chemours (NYSE:CC)
Insider Trades by Quarter for Chemours (NYSE:CC)

Chemours (NYSE CC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Paul KirschInsiderSell13,770$50.01$688,637.7063,093View SEC Filing  
12/13/2017Christian W. SiemerInsiderSell15,088$47.37$714,718.56View SEC Filing  
11/6/2017E Bryan SnellInsiderSell11,878$53.25$632,503.5063,063View SEC Filing  
10/13/2017David C SheltonSVPSell5,908$56.01$330,907.0847,356View SEC Filing  
10/10/2017David C SheltonSVPSell13,397$55.00$736,835.00View SEC Filing  
10/5/2017David C SheltonSVPSell19,000$53.68$1,019,920.00View SEC Filing  
9/5/2017E Bryan SnellInsiderSell13,000$49.35$641,550.00View SEC Filing  
8/31/2017David C. SheltonSVPSell13,337$48.48$646,577.76View SEC Filing  
8/11/2017Amy TrojanowskiVPSell2,500$46.03$115,075.00View SEC Filing  
8/11/2017E Bryan SnellInsiderSell10,000$46.24$462,400.00View SEC Filing  
6/5/2017Paul KirschInsiderSell19,036$41.42$788,471.12View SEC Filing  
5/16/2017Erich ParkerVPSell4,908$45.53$223,461.24View SEC Filing  
5/5/2017Mark NewmanVPSell22,781$39.83$907,367.23View SEC Filing  
5/3/2017Richard H. BrownDirectorBuy2,500$39.10$97,750.00View SEC Filing  
5/13/2016Mark NewmanCFOBuy2,800$9.71$27,188.00108,533View SEC Filing  
5/4/2016Bradley J BellDirectorBuy10,000$9.65$96,500.0021,747View SEC Filing  
2/26/2016Stephen D. NewlinDirectorBuy10,000$4.94$49,400.00View SEC Filing  
11/23/2015Thierry Fj VanlanckerInsiderBuy15,000$6.00$90,000.00190,022View SEC Filing  
9/14/2015E Bryan SnellInsiderBuy8,000$8.89$71,120.0022,051View SEC Filing  
9/11/2015Amy TrojanowskiVPBuy5,400$9.24$49,896.0011,982View SEC Filing  
9/10/2015Christian W SiemerInsiderBuy10,100$9.39$94,839.0031,843View SEC Filing  
9/9/2015Mark NewmanCFOBuy10,600$9.32$98,792.00114,109View SEC Filing  
9/8/2015Christian W SiemerInsiderBuy11,000$9.11$100,210.0021,743View SEC Filing  
9/4/2015David C SheltonSVPBuy5,000$9.00$45,000.0013,183View SEC Filing  
9/4/2015Mark P VergnanoCEOBuy72,600$9.25$671,550.00321,337View SEC Filing  
9/4/2015Stephen D. NewlinDirectorBuy7,000$9.18$64,260.0016,680View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Chemours (NYSE CC) News Headlines

Source:
DateHeadline
Insider Selling: Chemours Co (CC) Insider Sells 13,770 Shares of StockInsider Selling: Chemours Co (CC) Insider Sells 13,770 Shares of Stock
www.americanbankingnews.com - February 23 at 12:12 AM
Cyanco Intermediate 2 Corp. -- Moodys assigns B2 CFR to Cyanco Intermediate 2 Corp.Cyanco Intermediate 2 Corp. -- Moody's assigns B2 CFR to Cyanco Intermediate 2 Corp.
finance.yahoo.com - February 22 at 9:46 AM
Chemours (CC) Upgraded by Zacks Investment Research to "Strong-Buy"Chemours (CC) Upgraded by Zacks Investment Research to "Strong-Buy"
www.americanbankingnews.com - February 21 at 8:52 PM
Chemours Co Expected to Post FY2019 Earnings of $6.10 Per Share (CC)Chemours Co Expected to Post FY2019 Earnings of $6.10 Per Share (CC)
www.americanbankingnews.com - February 21 at 3:32 PM
 Analysts Anticipate Chemours Co (CC) Will Post Earnings of $1.19 Per Share Analysts Anticipate Chemours Co (CC) Will Post Earnings of $1.19 Per Share
www.americanbankingnews.com - February 17 at 9:08 PM
The Chemours Company Announces Promotion of Edwin Sparks to President of the Chemical Solutions Segment Following the Anticipated Departure of Chris SiemerThe Chemours Company Announces Promotion of Edwin Sparks to President of the Chemical Solutions Segment Following the Anticipated Departure of Chris Siemer
finance.yahoo.com - February 15 at 4:19 PM
Chemours shares rise after earnings beat - MarketWatchChemours shares rise after earnings beat - MarketWatch
www.marketwatch.com - February 15 at 6:13 AM
Chemours shares rise after earnings beatChemours shares rise after earnings beat
finance.yahoo.com - February 15 at 6:13 AM
The Chemours Company Announces Changes to its Board of DirectorsThe Chemours Company Announces Changes to its Board of Directors
finance.yahoo.com - February 15 at 6:13 AM
The Chemours Company Reports Fourth Quarter and Full Year 2017 Results; Robust Performance Across All Segments and Key Financial MetricsThe Chemours Company Reports Fourth Quarter and Full Year 2017 Results; Robust Performance Across All Segments and Key Financial Metrics
finance.yahoo.com - February 15 at 6:13 AM
Chemours beats 4Q profit forecastsChemours beats 4Q profit forecasts
finance.yahoo.com - February 15 at 6:13 AM
Chemours (CC) Announces Quarterly  Earnings ResultsChemours (CC) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 14 at 9:14 PM
Chemours (CC) Issues FY18 Earnings GuidanceChemours (CC) Issues FY18 Earnings Guidance
www.americanbankingnews.com - February 14 at 5:10 PM
Did The Chemours Company (NYSE:CC) Create Value For Shareholders?Did The Chemours Company (NYSE:CC) Create Value For Shareholders?
finance.yahoo.com - February 14 at 3:23 PM
A Preview Of Chemours Q4 EarningsA Preview Of Chemours Q4 Earnings
finance.yahoo.com - February 14 at 3:23 PM
Chemours Co (CC) Receives Average Rating of "Buy" from BrokeragesChemours Co (CC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 14 at 11:48 AM
Univar (UNVR) Announces Exclusive Distribution Agreement in US with Chemours Co. (CC) for Hydrochloric Acid - StreetInsider.comUnivar (UNVR) Announces Exclusive Distribution Agreement in US with Chemours Co. (CC) for Hydrochloric Acid - StreetInsider.com
www.streetinsider.com - February 13 at 6:14 AM
Bullish Two Hundred Day Moving Average Cross - CC - Nasdaq.com - NasdaqBullish Two Hundred Day Moving Average Cross - CC - Nasdaq.com - Nasdaq
www.nasdaq.com - February 13 at 6:14 AM
Is a Surprise Coming for Chemours (CC) This Earnings Season?Is a Surprise Coming for Chemours (CC) This Earnings Season?
finance.yahoo.com - February 12 at 3:22 PM
Chemours Co (CC) Plans Quarterly Dividend of $0.17Chemours Co (CC) Plans Quarterly Dividend of $0.17
www.americanbankingnews.com - February 9 at 11:14 AM
Dupont, Chemours Sued by Ohio Over Cancer-Linked Teflon ToxinDupont, Chemours Sued by Ohio Over Cancer-Linked Teflon Toxin
finance.yahoo.com - February 9 at 6:10 AM
Chemours (CC) to Release Earnings on WednesdayChemours (CC) to Release Earnings on Wednesday
www.americanbankingnews.com - February 7 at 1:38 AM
Celanese Increases Prices of Polymer ProductsCelanese Increases Prices of Polymer Products
finance.yahoo.com - January 30 at 3:20 PM
Contrasting Chemours (CC) & Verenium (VRNM)Contrasting Chemours (CC) & Verenium (VRNM)
www.americanbankingnews.com - January 25 at 9:02 PM
Whats Happening With These Specialty Chemicals Stocks? -- Albemarle, Chemours, WR Grace, and Kronos Worldwide - PR Newswire (press release)What's Happening With These Specialty Chemicals Stocks? -- Albemarle, Chemours, WR Grace, and Kronos Worldwide - PR Newswire (press release)
www.prnewswire.com - January 25 at 3:21 PM
Chemours Asked to Test Water for Teflon Agent by "Concerned" EPAChemours Asked to Test Water for Teflon Agent by "Concerned" EPA
finance.yahoo.com - January 25 at 3:21 PM
Chemours Co (CC) Receives Consensus Recommendation of "Buy" from AnalystsChemours Co (CC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 20 at 2:04 PM
Chemours Announces Dates for Fourth Quarter and Full-Year 2017 Earnings Release and Webcast Conference CallChemours Announces Dates for Fourth Quarter and Full-Year 2017 Earnings Release and Webcast Conference Call
finance.yahoo.com - January 18 at 4:34 PM
Interesting CC Put And Call Options For February 16th - Nasdaq.com - NasdaqInteresting CC Put And Call Options For February 16th - Nasdaq.com - Nasdaq
www.nasdaq.com - January 2 at 11:17 PM
How Financially Strong Is The Chemours Company (NYSE:CC)?How Financially Strong Is The Chemours Company (NYSE:CC)?
finance.yahoo.com - December 28 at 5:28 AM
Chemours Co (CC) Given Average Rating of "Buy" by BrokeragesChemours Co (CC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 26 at 2:38 PM
Chemours to Increase Fluoropolymer PricesChemours to Increase Fluoropolymer Prices
finance.yahoo.com - December 26 at 9:19 AM
Chemours Announces Fluoropolymer Price IncreaseChemours Announces Fluoropolymer Price Increase
finance.yahoo.com - December 21 at 9:50 AM
Chemours Breaks Ground on New State-of-the-Art Innovation Center, The Chemours Discovery Hub, on the University of Delawares Science Technology and Advanced Research CampusChemours Breaks Ground on New State-of-the-Art Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science Technology and Advanced Research Campus
www.prnewswire.com - December 18 at 1:52 PM
Contrasting Ingevity (NGVT) and Chemours (CC)Contrasting Ingevity (NGVT) and Chemours (CC)
www.americanbankingnews.com - December 18 at 7:50 AM
Chemours Co (CC) Insider Sells $714,718.56 in StockChemours Co (CC) Insider Sells $714,718.56 in Stock
www.americanbankingnews.com - December 15 at 11:34 PM
Chemours (CC) Stock Rating Lowered by Zacks Investment ResearchChemours (CC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - December 6 at 7:11 PM
Barclays Reiterates "Buy" Rating for Chemours (CC)Barclays Reiterates "Buy" Rating for Chemours (CC)
www.americanbankingnews.com - December 6 at 11:58 AM
3 Embarrassingly Low Dividend Stocks3 Embarrassingly Low Dividend Stocks
finance.yahoo.com - December 6 at 9:59 AM
Goldman Sachs Group Lowers Chemours (CC) to NeutralGoldman Sachs Group Lowers Chemours (CC) to Neutral
www.americanbankingnews.com - December 6 at 8:36 AM
Analysts Offer Predictions for Chemours Company (The)s FY2017 Earnings (CC)Analysts Offer Predictions for Chemours Company (The)'s FY2017 Earnings (CC)
www.americanbankingnews.com - December 6 at 7:34 AM
Chemours’ stock drops as tax-inspired profit-taking offsets ‘attractive’ reform benefitsChemours’ stock drops as tax-inspired profit-taking offsets ‘attractive’ reform benefits
finance.yahoo.com - December 5 at 10:31 AM
These 3 Stocks Are Priced for Perfection -- Can They Deliver?These 3 Stocks Are Priced for Perfection -- Can They Deliver?
finance.yahoo.com - December 5 at 10:31 AM
Zacks.com highlights: Home Depot, Primerica, Broadridge Financial Solutions and ChemoursZacks.com highlights: Home Depot, Primerica, Broadridge Financial Solutions and Chemours
finance.yahoo.com - December 5 at 10:31 AM
Equities Analysts Set Expectations for Chemours Company (The)s Q4 2017 Earnings (CC)Equities Analysts Set Expectations for Chemours Company (The)'s Q4 2017 Earnings (CC)
www.americanbankingnews.com - December 5 at 9:04 AM
Chemours (CC) Board Authorizes Share Repurchase PlanChemours (CC) Board Authorizes Share Repurchase Plan
www.americanbankingnews.com - December 4 at 11:10 AM
Chambers Cogeneration Ltd. Partnership -- Moodys affirms Chambers Cogeneration at Baa3, stable; following planned change in ownershipChambers Cogeneration Ltd. Partnership -- Moody's affirms Chambers Cogeneration at Baa3, stable; following planned change in ownership
finance.yahoo.com - December 4 at 9:49 AM
Chemours (CC) Price Target Raised to $66.00 at Jefferies GroupChemours (CC) Price Target Raised to $66.00 at Jefferies Group
www.americanbankingnews.com - December 4 at 8:52 AM
Chemours (CC) Offers Outlook at Investor Day and Approves $500M Buyback - StreetInsider.comChemours (CC) Offers Outlook at Investor Day and Approves $500M Buyback - StreetInsider.com
www.streetinsider.com - December 2 at 4:53 PM
Heres Why You Should Invest in Chemours (CC) Stock Now - NasdaqHere's Why You Should Invest in Chemours (CC) Stock Now - Nasdaq
www.nasdaq.com - December 2 at 4:53 PM

SEC Filings

Chemours (NYSE:CC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Chemours (NYSE:CC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Chemours (NYSE CC) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.